A variant erythroferrone disrupts iron homeostasis in SF3B1 -mutated myelodysplastic syndrome
Author(s) -
Sabrina Bondu,
AnneSophie Alary,
Carine Lefèvre,
Alexandre Houy,
Grace Jung,
Thibaud Lefèbvre,
David Rombaut,
Ismael Boussaïd,
Abderrahmane Bousta,
François Guillonneau,
Prunelle Perrier,
Samar Alsafadi,
Michel Wassef,
Raphaël Margueron,
Alice Rousseau,
Nathalie Droin,
Nicolas Cagnard,
Sophie Kaltenbach,
Susann Winter,
Anne Sophie Kubasch,
Didier Bouscary,
Valeria Santini,
Andréa Toma,
Mathilde Hunault,
Aspasia Stamatoullas,
Emmanuel Gyan,
Thomas Cluzeau,
Uwe Platzbecker,
Lionel Adès,
Hervé Puy,
MarcHenri Stern,
Zoubida Karim,
Patrick Mayeux,
Elizabeta Nemeth,
Sophie Park,
Tomas Ganz,
Léon Kautz,
Olivier Kosmider,
Michaëla Fontenay
Publication year - 2019
Publication title -
science translational medicine
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 6.819
H-Index - 216
eISSN - 1946-6242
pISSN - 1946-6234
DOI - 10.1126/scitranslmed.aav5467
Subject(s) - hepcidin , iron homeostasis , homeostasis , cancer research , medicine , endocrinology , anemia , metabolism
A variant erythroferrone contributes to hepcidin modulation and systemic iron accumulation in patients withSF3B1 -mutated myelodysplastic syndrome.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom